Celldex Therapeutics
The Vice President, Clinical Science & Clinical Development serves as a senior medical and scientific leader within Celldex's Clinical organization, partnering with the Chief Medical Officer to shape and execute clinical development strategies. This role oversees clinical programs from proof of concept through late-stage development and post-marketing phases, ensuring high-quality execution and regulatory approval. The position involves leading clinical trial design, data interpretation, and scientific communication while building and mentoring the Clinical Development team.
Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering immunology-based therapies to treat severe inflammatory, allergic, and autoimmune diseases. Their lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT designed to target mast cells as a core driver of disease. The company leverages deep expertise in antibody-based immunotherapies and proprietary technologies to discover and develop innovative treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celldex Therapeutics.
197% above the average for this role
Vice President, Clinical Development
Tarsus Pharmaceuticals
Vice President, Clinical Development
Tarsus Pharmaceuticals
Senior Director, Clinical Science
CytomX Therapeutics
Senior Vice President Clinical Development
Qpex Biopharma
Vice President (VP), Clinical Development - Infectious Disease
Tonix Pharmaceuticals
Vice President, Clinical Development
Tarsus Pharmaceuticals